Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03690141
Title A Study Examining the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (CRPC)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Effector Therapeutics

prostate adenocarcinoma



Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Kimmel Center at Johns Hopkins Baltimore Maryland 21205 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
The Urology Group Cincinnati Ohio 45212 United States Details
Lancaster Urology Lancaster Pennsylvania 17604 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
University of Washington Seattle Washington 89109 United States Details
*Shaded cells indicate that there was no data available from for the field